Reduced Exposure To Harmful And Potentially Harmful Constituents after 90 Days Of Use Of Tobacco Heating System 2.2 Menthol In Japan: A Comparison With Continued Cigarette Use Or Smoking Abstinence Posters posters Clinicalclinical Nov 10, 2015 20151110 /content/dam/pmiscience/default-fallback-thumbnails/publication/fallback7.png
      Posters

      Reduced Exposure To Harmful And Potentially Harmful Constituents after 90 Days Of Use Of Tobacco Heating System 2.2 Menthol In Japan: A Comparison With Continued Cigarette Use Or Smoking Abstinence

      Haziza, C.; Lama, N.; Donelli, A.; Picavet, P.; Baker, G.; Ancerewicz, J. Ancerewicz.; Benzimra, M.; Franzon, M.; Endo, M.; Lüdicke, F.
      Conference date
      Nov 10, 2015
      Conference name
      American College of Toxicology (ACT) 2015
      Link to more information
      Link to more information
      Topic
      Summary

      The Tobacco Heating System 2.2 menthol (mTHS) was developed to reduce or eliminate the formation of harmful and potentially harmful smoke constituents (HPHCs) in the aerosol through heating and not burning tobacco, while preserving as much as possible taste, sensory experience, nicotine delivery profile and ritual characteristics of menthol cigarettes(mCC). The study reported is part of a global clinical program for THS and was designed to demonstrate sustained exposure reduction to selected HPHCs in smokers pre –dominantly using mTHS and to provide first insight on changes in clinical risk endpoints(CRE)when switching from mCC to mTHS use for 5 days in confinement followed by an ambulatory period of 85 days, compared to subjects continuing to smoke mCC and those who abstained from smoking.Biomarkers of exposure (BoExp) to 16 HPHCs were assessed to provide an assessment of human uptake of a variety of representative toxicants contained in combustible tobacco products. Selected CREs associated with cardiovascular, respiratory disease and genotoxicity as well as subjective effects to investigate the acceptance of mTHS compared to mCC were also assessed in this study.

      Related Publications

      Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol Tobacco Heating System 2.2 for three months (Part 1)

      Clinical

      Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol Tobacco Heating System 2.2 for three months (Part 1)

      Clinical

      Meta-analysis of the effects of smoking and smoking cessation on triglyceride levels

      Clinical

      Smoking and apolipoprotein levels: A meta-analysis of published data

      Clinical

      Effect of switching from cigarette smoking to the use of the tobacco heating system on periodontitis treatment outcome: Periodontal parameter results from a multicenter Japanese study

      Clinical

      Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate Modified Risk Tobacco Product: A randomized trial

      Clinical

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.